Venture Life Group (LON:VLG) Stock Price Passes Above 50 Day Moving Average – Should You Sell?

Venture Life Group plc (LON:VLG) shares passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 57.25 and traded as high as GBX 62. Venture Life Group shares last traded at GBX 61.50, with a volume of 271,131 shares.

Venture Life Group Price Performance

The stock has a 50 day moving average of GBX 57.25 and a two-hundred day moving average of GBX 56.89. The company has a debt-to-equity ratio of 28.45, a quick ratio of 1.48 and a current ratio of 2.22. The stock has a market cap of £81.27 million, a PE ratio of -83.80, a PEG ratio of 5.67 and a beta of 0.30.

Venture Life Group (LON:VLG) last announced its earnings results on Tuesday, September 30th. The company reported GBX 0.83 EPS for the quarter. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%. Equities analysts anticipate that Venture Life Group plc will post 6.1391542 EPS for the current year.

Insiders Place Their Bets

In other news, insider Mark Adams bought 88,999 shares of the business’s stock in a transaction on Friday, October 3rd. The shares were bought at an average cost of GBX 56 per share, with a total value of £49,839.44. Insiders own 6.84% of the company’s stock.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.